Arkolith/Insider Trading/KDNY/Form 4

Oxtoby Andrew

Chief Commercial OfficerCHINOOK THERAPEUTICS, INC. (KDNY) · full profile →Form 4 · filed Aug 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)40K——0
Aug 11, 2023Disposed to issuer(D)160K$18.18$2.9M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045429) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML